New pain block beats standard injection after gallbladder surgery
NCT ID NCT07176299
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested different ways to control pain after laparoscopic gallbladder removal in 160 adults. Patients received either a TAP block (an injection into the abdominal wall muscles), local anesthetic at the incision sites, both, or no extra pain relief. The TAP block group reported less pain and had fewer wound problems in the first 24 hours after surgery, suggesting it is a safe and effective option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bupivacaine
What this could lead to
If this method proves better, it could become a standard way to manage pain after gallbladder surgery, reducing the need for strong painkillers.
What could go wrong
This is a completed study, so results are final. However, it only looked at short-term pain up to 24 hours, and the benefits may not apply to other surgeries or longer recovery periods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLELITHIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Clinical Hospital in Olsztyn
Olsztyn, Warmian-Masurian Voivodeship, 11-041, Poland